• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regulatory science of natural products.天然产物的监管科学。
J Nat Med. 2022 Sep;76(4):732-747. doi: 10.1007/s11418-022-01639-w. Epub 2022 Jul 23.
2
Comparison of the contents of kampo decoctions containing ephedra herb when prepared simply or by re-boiling according to the traditional theory.比较按传统理论简单煎煮或再煎煮法制备的含麻黄草药的汉方药汤液的内容物。
J Nat Med. 2010 Jan;64(1):70-4. doi: 10.1007/s11418-009-0375-z. Epub 2009 Nov 27.
3
Regulation of traditional herbal medicinal products in Japan.日本传统草药产品的监管
J Ethnopharmacol. 2014 Dec 2;158 Pt B:511-5. doi: 10.1016/j.jep.2014.07.012. Epub 2014 Jul 17.
4
[Our Approaches to the New Drug Application of Ephedrine Alkaloids-free Ephedra Herb Extract (EFE): Toward Breakthrough in Natural Medicines in Japan].[我们对无麻黄碱麻黄草提取物(EFE)新药申请的方法:迈向日本天然药物的突破]
Yakugaku Zasshi. 2017;137(2):161-162. doi: 10.1248/yakushi.16-00233-F.
5
Challenges in the quality of herbal medicinal products with a specific focus on contaminants.草药药品质量面临的挑战,尤其关注污染物。
Phytochem Anal. 2021 Apr;32(2):117-123. doi: 10.1002/pca.2879. Epub 2019 Aug 11.
6
Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1.日本传统汉方药中使用的生药提取物与有机阴离子转运多肽 2B1 的相互作用。
J Ethnopharmacol. 2018 Mar 25;214:153-159. doi: 10.1016/j.jep.2017.12.016. Epub 2017 Dec 14.
7
Regulatory issues concerning the safety, efficacy and quality of herbal remedies.关于草药疗法的安全性、有效性和质量的监管问题。
Birth Defects Res B Dev Reprod Toxicol. 2003 Dec;68(6):505-10. doi: 10.1002/bdrb.10053.
8
[A Basis for Pharmaceutical Sciences "Quality Assurance": Quality Assurance of Health Foods, Foods with Health Claims, and Pharmaceutics].[药学科学“质量保证”的基础:保健食品、具有健康声称的食品及药剂学的质量保证]
Yakugaku Zasshi. 2021;141(6):787-791. doi: 10.1248/yakushi.20-00217-2.
9
Future development of global regulations of Chinese herbal products.中草药全球监管法规的未来发展。
J Ethnopharmacol. 2012 Apr 10;140(3):568-86. doi: 10.1016/j.jep.2012.02.029. Epub 2012 Feb 25.
10
Natural products as starting points for future anti-malarial therapies: going back to our roots?天然产物作为未来抗疟疗法的起点:回归本源?
Malar J. 2011 Mar 15;10 Suppl 1(Suppl 1):S3. doi: 10.1186/1475-2875-10-S1-S3.

引用本文的文献

1
Advanced multidimensional quality evaluation of encapsulated peppermint oil products in various formulas.不同配方中胶囊薄荷油产品的先进多维质量评估
J Nat Med. 2025 Jul 18. doi: 10.1007/s11418-025-01934-2.
2
From traditional medicine to modern medicine: the importance of TCM regulatory science (TCMRS) as an emerging discipline.从传统医学到现代医学:中医监管科学(TCMRS)作为一门新兴学科的重要性。
Chin Med. 2025 Jun 26;20(1):92. doi: 10.1186/s13020-025-01152-8.
3
Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities.将实施科学框架应用于不同国家监管机构中开发和采用监管科学。
Front Public Health. 2023 May 4;11:1172557. doi: 10.3389/fpubh.2023.1172557. eCollection 2023.

本文引用的文献

1
Determination of Absolute Purities of Hygroscopic Substances by Quantitative NMR Analysis for the Standardization of Quantitative Reagents in the Japanese Pharmacopoeia (Part 2).吸湿物质的定量 NMR 分析测定其绝对纯度用于日本药典中定量试剂的标准化(第 2 部分)。
Chem Pharm Bull (Tokyo). 2021;69(1):26-31. doi: 10.1248/cpb.c20-00296.
2
[Determination of Absolute Purities of Hygroscopic Substances by Quantitative NMR Analysis for the Standardization of Quantitative Reagents in the Japanese Pharmacopoeia (Part 1)].[通过定量核磁共振分析测定吸湿物质的绝对纯度以实现日本药典中定量试剂的标准化(第1部分)]
Yakugaku Zasshi. 2020;140(8):1063-1069. doi: 10.1248/yakushi.20-00066.
3
Quality Evaluation and Characterization of Fractions with Biological Activity from Ephedra Herb Extract and Ephedrine Alkaloids-Free Ephedra Herb Extract.麻黄草提取物及去麻黄碱生物碱麻黄草提取物中具有生物活性组分的质量评价与表征
Chem Pharm Bull (Tokyo). 2020;68(2):140-149. doi: 10.1248/cpb.c19-00761.
4
[The Adverse Effects of Ephedra Herb and the Safety of Ephedrine Alkaloids-free Ephedra Herb Extract (EFE)].麻黄草的不良反应及无麻黄碱类生物碱麻黄草提取物(EFE)的安全性
Yakugaku Zasshi. 2019;139(11):1417-1425. doi: 10.1248/yakushi.19-00122.
5
Analgesic Effects of Ephedra Herb Extract, Ephedrine Alkaloids-Free Ephedra Herb Extract, Ephedrine, and Pseudoephedrine on Formalin-Induced Pain.麻黄草药提取物、不含麻黄碱的麻黄草药提取物、麻黄碱和伪麻黄碱对福尔马林诱导疼痛的镇痛作用。
Biol Pharm Bull. 2019;42(9):1538-1544. doi: 10.1248/bpb.b19-00260.
6
A Double-Blind, Randomized, Crossover Comparative Study for Evaluating the Clinical Safety of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE).一项评估无麻黄碱麻黄草提取物(EFE)临床安全性的双盲、随机、交叉对照研究。
Evid Based Complement Alternat Med. 2018 Aug 5;2018:4625358. doi: 10.1155/2018/4625358. eCollection 2018.
7
Fluorescence Coupled with Macro and Microscopic Examinations of Morphological Phenotype Give Key Characteristics for Identification of Crude Drugs Derived from Scorpions.荧光结合宏观和微观形态表型检查为鉴定蝎源生药提供关键特征。
Biol Pharm Bull. 2018;41(4):510-523. doi: 10.1248/bpb.b17-00801.
8
Ephedrine Alkaloids-Free Ephedra Herb Extract, EFE, Has No Adverse Effects Such as Excitation, Insomnia, and Arrhythmias.不含麻黄碱的麻黄草药提取物,EFE,没有兴奋、失眠和心律失常等不良反应。
Biol Pharm Bull. 2018;41(2):247-253. doi: 10.1248/bpb.b17-00803.
9
Disintegration Test of Health Food Products Containing L. or L. in the Japanese Market.日本市场上含嗜酸乳杆菌或干酪乳杆菌保健食品的崩解试验。
Medicines (Basel). 2015 Apr 23;2(2):47-54. doi: 10.3390/medicines2020047.
10
Two flavone C-glycosides as quality control markers for the manufacturing process of ephedrine alkaloids-free Ephedra Herb extract (EFE) as a crude drug preparation.两种黄酮碳苷作为无麻黄碱类生物碱麻黄草提取物(EFE)粗药制剂生产过程中的质量控制标志物。
J Nat Med. 2018 Jan;72(1):73-79. doi: 10.1007/s11418-017-1111-8. Epub 2017 Aug 3.

天然产物的监管科学。

Regulatory science of natural products.

机构信息

National Institute of Health Sciences, 25-26 Tonomachi 3-chome, Kawasaki-ku, Kawasaki, 210-9501, Japan.

出版信息

J Nat Med. 2022 Sep;76(4):732-747. doi: 10.1007/s11418-022-01639-w. Epub 2022 Jul 23.

DOI:10.1007/s11418-022-01639-w
PMID:35870047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9307968/
Abstract

Foods and pharmaceuticals play key roles in public health and welfare and ensuring that these products meet their quality assurance standards is a top priority in health and medical care. Quality assurance of natural products is essential in pharmaceutical sciences because the outset of a medicine is a natural, crude drug. Regulatory science underpins scientific regulations and is closely related to the quality assurance of foods and pharmaceuticals to ensure their safety and efficacy. During my time at the National Institute of Health Sciences, Japan, from 1986 to present, the regulatory science of natural products has been my main research focus. This review discusses 24 studies related to the regulatory science of natural food additives, 26 related to foods, 23 related to borderline products, 16 related to illicit psychotropic mushrooms, plants, and agents, and 57 related to herbal medicines. In later sections, the regulatory science for ethical Kampo products with new dosage forms and herbal medicines that use Kampo extracts as active pharmaceutical ingredients are discussed. My experience from the early twenty-first century in research projects on the bioequivalence of Kampo products and the development of ephedrine alkaloid-free Ephedra Herb extract demonstrate that regulatory science is crucial for developing new drugs.

摘要

食品和药品在公共卫生和福利中起着关键作用,确保这些产品符合质量保证标准是医疗保健的首要任务。天然产品的质量保证在制药科学中至关重要,因为药物的起点是天然的、粗制药物。监管科学是科学法规的基础,与食品和药品的质量保证密切相关,以确保它们的安全性和有效性。在我 1986 年至今在日本国立保健医疗科学院的任职期间,天然产品的监管科学一直是我的主要研究重点。这篇综述讨论了 24 项与天然食品添加剂监管科学相关的研究、26 项与食品相关的研究、23 项与边缘产品相关的研究、16 项与非法精神蘑菇、植物和制剂相关的研究以及 57 项与草药相关的研究。在后面的部分中,讨论了具有新剂型的伦理坎波产品和使用坎波提取物作为活性药物成分的草药的监管科学。我在 21 世纪初参与的关于坎波产品生物等效性的研究项目和无麻黄碱麻黄草药提取物的开发经验表明,监管科学对于开发新药至关重要。